Expression profiling of osteosarcoma cells transfected with MDR1 and NEO genes: Regulation of cell adhesion, apoptosis, and tumor suppression-related genes

Laboratory Investigation

Volumn 83, Issue 4, 2003, Pages 507-517

  Sanchez Carbayo, Marta ^a   Belbin, Thomas J ^b   Scotlandi, Katia ^c   Prystowsky, Michael ^b   Baldini, Nicola ^c   Childs, Geoffrey ^b   Cordon Cardo, Carlos ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DOXORUBICIN; DYNAMIN; EPHRIN; NEOMYCIN; RNA; RNA BINDING PROTEIN; TELOMERASE;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MOLECULAR CLONING; MULTIDRUG RESISTANCE; MUTATION; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE; UNINDEXED SEQUENCE;

EID: 0345269134     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.LAB.0000064702.63200.94     Document Type: Article

References (48)

1. Adams J, Palombella VJ, and Elliott PJ (2000). Proteasome inhibition: A new strategy in cancer treatment. Invest New Drugs 18:109-121.
2. Biedler JL and Spengler BA (1994). Reverse transformation of multidrug-resistant cells. Cancer Metastasis Rev 13:191-207.
3. Callow MJ, Dudoit S, Gong EL, Speed TP, and Rubin EM (2000). Microarray expression profiling identifies genes with altered expression in HDL-deficient mice. Genome Res 10:2022-2029.
4. Chambers JK, Macdonald LE, Sarau HM, Ames RS, Freeman K, Foley JJ, Zhu Y, McLaughlin MM, Murdock P, McMillan L, Trill J, Swift A, Aiyar N, Taylor P, Vawter L, Naheed S, Szekeres P, Hervieu G, Scott C, Watson JM, Murphy AJ, Duzic E, Klein C, Bergsma DJ, Wilson S, and Livi GP (2000). A G protein-coupled receptor for UDP-glucose. J Biol Chem 275:10767-10771.
5. Chan HS, Grogan TM, Haddad G, DeBoer G, and Ling V (1997). P-glycoprotein expression: Critical determinant in the response to osteosarcoma chemotherapy. J Natl Cancer Inst 89:1706-1715.
6. Cheung VG, Morley M, Aguilar F, Massimi A, Kucherlapati R, and Childs G (1999). Making and reading microarrays. Nat Genet 21:15-19.
7. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, and Melamed MR (1990). Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277-1287.
8. Damiano JS, Cress AE, Hazlehurst LA, Shtil AA, and Dalton WS (1999). Cell adhesion mediated drug resistance (CAM-DR): Role of integrins and resistance to apoptosis in human myeloma cell lines. Blood 93:1658-1667.
9. Dano K (1973). Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim Biophys Acta 323:466-483.
10. Desoize B, Gimonet D, and Jardillier JC (1998). Multicellular resistance: Another mechanism for multidrug resistance? Bull Cancer 85:785.
11. Eisen MB, Spellman PT, Brown PO, and Botstein D (1998). Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863-14868.
12. Gottesman MM and Pastan I (1993). Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62:385-427.
13. Gudkov AV, Kazarov AR, Thimmapaya R, Axenovich SA, Mazo IA, and Roninson IB (1994). Cloning mammalian genes by expression selection of genetic suppressor elements: Association of kinesin with drug resistance and cell immortalization. Proc Natl Acad Sci USA 91:3744-3748.
14. Hirayama S, Bujo H, Yamazaki H, Kanaki T, Takahashi K, Kobayashi J, Schneider WJ, and Salto Y (2000). Differential expression of LR11 during proliferation and differentiation of cultured neuroblastoma cells. Biochem Biophys Res Commun 275:365-373.
15. Hirota T, Morisaki T, Nishiyama Y, Marumoto T, Tada K, Hara T, Masuko N, Inagaki M, Hatakeyama K, and Saya H (2000). Zyxin, a regulator of actin filament assembly, targets the mitotic apparatus by interacting with h-warts/LATS1 tumor suppressor. J Cell Biol 149:1073-1086.
16. Johnstone RW, Cretney E, and Smyth MJ (1999). P-glycoprotein protects leukemia cells against caspase-dependent, but not caspase-independent, cell death. Blood 93:1075-1085.
17. Kim CH and Gupta S (2000). Expression of TRAIL (Apo2L), DR4 (TRAIL receptor 1), DR5 (TRAIL receptor 2) and TRID (TRAIL receptor 3) genes in multidrug resistant human acute myeloid leukemia cell lines that overexpress MDR 1 (HL60/ Tax) or MRP (HL60/AR). Int J Oncol 16:1137-1139.
18. Kudoh K, Ramanna M, Ravatn R, Elkahloun AG, Bittner ML, Meltzer PS, Trent JM, Dalton WS, and Chin KV (2000). Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. Cancer Res 60:4161-4166.
19. Le S, Sternglanz R, and Greider CW (2000). Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell 11:999-1010.
20. Lee CG, Ramachandra M, Jeang KT, Martin MA, Pastan I, and Gottesman MM (2000). Effect of ABC transporters on HIV-1 infection: Inhibition of virus production by the MDR1 transporter. FASEB J 14:516-522.
21. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent JM, Weissman BE, and Welch DR (1996). KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Natl Cancer Inst 88:1731-1737.
22. Lee JH and Welch DR (1997). Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res 57:2384-2387.
23. Lee M, Hwang I, Choi Y, Paik S, Lee HB, and Baik M (1997). EGF inhibits expression of WDNM1 and sulfated glycoprotein-2 genes in mammary epithelial cells. Biochem Biophys Res Commun 240:104-107.
24. Lu C, Rak JW, Kobayashi H, and Kerbel RS (1993). Increased resistance to oncostatin M-induced growth inhibition of human melanoma cell lines derived from advanced-stage lesions. Cancer Res 53:2708-2711.
25. Marks PW, Arai M, Bandura JL, and Kwiatkowski DJ (1998). Advillin (p92): A new member of the gelsolin/villin family of actin regulatory proteins. J Cell Sci 111:2129-2136.
26. Miyazaki K, Hattori Y, Umenishi F, Yasumitsu H, and Umeda M (1990). Purification and characterization of extracellular matrix-degrading metalloproteinase, matrin (pump-1), secreted from human rectal carcinoma cell line. Cancer Res 50:7758-7764.
27. Modregger J, Ritter B, Witter B, Paulsson M, and Plomann M (2000). All three PACSIN isoforms bind to endocytic proteins and inhibit endocytosis. J Cell Sci 113:4511-4521.
28. Okazaki M, Takeshita S, Kawai S, Kikuno R, Tsujimura A, Kudo A, and Amann E (1994). Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem 269:12092-12098.
29. Roepe PD (2000). What is the precise role of human MDR 1 protein in chemotherapeutic drug resistance? Curr Pharm Des 6:241-260.
30. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, van Tellingen O, Zijlmans JM, Fibbe WE, and Borst P (1997). Normal viability and altered pharmacokinetics in mice lacking mdrl-type (drug-transporting) P-glycoproteins. Proc Natl Acad Sci USA 94:4028-4033.
31. Schroeder R, Waldsich C, and Wank H (2000). Modulation of RNA function by aminoglycoside antibiotics. EMBO J 19:1-9.
32. Schwartz D and Beitner R (2000). Detachment of the glycolytic enzymes, phosphofructokinase and aldolase, from cytoskeleton of melanoma cells, induced by local anesthetics. Mol Genet Metab 69:159-164.
33. Scotlandi K, Manara MC, Serra M, Benini S, Maunci D, Caputo A, De Giovanni C, Lollini PL, Nanni P, Picci P, Campanacci M, and Baldini N (1999). The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells. Oncogene 18:739-746.
34. Scotlandi K, Serra M, Nicoletti G, Vaccari M, Manara MC, Nini G, Landuzzi L, Colacci A, Bacci G, Bertoni F, Picci P, Campanacci M, and Baldini N (1996). Multidrug resistance and malignancy in human osteosarcoma. Cancer Res 56: 2434-2439.
35. Sinha BK, Yamazaki H, Eliot HM, Schneider E, Borner MM, and O'Connor PM (1995). Relationships between proto-oncogene expression and apoptosis induced by anticancer drugs in human prostate tumor cells. Biochim Biophys Acta 1270:12-18.
36. St. Croix B and Kerbel RS (1997). Cell adhesion and drug resistance in cancer. Curr Opin Oncol 9:549-556.
37. Stears RL, Getts RC, and Gullans SR (2000). A novel, sensitive detection system for high-density microarrays using dendrimer technology. Physiol Genomics 3:93-99.
38. Takeshita H, Kusuzaki K, Ashihara T, Gebhardt MC, Mankin HJ, and Hirasawa Y (1998). Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance. Cancer Lett 126:75-81.
39. Tang XX, Evans AE, Zhao H, Cnaan A, London W, Cohn SL, Brodeur GM, and Ikegaki N (1999). High-level expression of EPHB6, EFNB2, and EFNB3 is associated with low tumor stage and high TrkA expression in human neuroblastomas. Clin Cancer Res 5:1491-1496.
40. Taniguchi M, Miura K, Iwao H, and Yamanaka S (2001). Quantitative assessment of DNA microarrays: Comparison with Northern blot analyses. Genomics 71:34-39.
41. Tenenhouse HS (1999). Recent advances in epithelial sodium-coupled phosphate transport. Curr Opin Nephrol Hypertens 8:407-414.
42. Therrien M, Wong AM, and Rubin GM (1998). CNK, a RAF-binding multidomain protein required for RAS signaling. Cell 95:343-353.
43. Trebak M, Begg GE, Chong JM, Kanazireva EV, Herlyn D, and Speicher DW (2001). Oligomeric state of the colon carcinoma-associated glycoprotein GA733-2 (Ep-CAM/ EGP40) and its role in GA733-mediated homotypic cell-cell adhesion. J Biol Chem 276:2299-2309.
44. Ueda K, Cardarelli C, Gottesman MM, and Pastan I (1987). Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 84:3004-3008.
45. Voehringer DW, Hirschberg DL, Xiao J, Lu Q, Roederer M, Lock CB, Herzenberg LA, Steinman L, and Herzenberg LA (2000). Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis. Proc Natl Acad Sci USA 97:2680-2685.
46. Wende H, Volz A, and Ziegler A (2000). Extensive gene duplications and a large inversion characterize the human leukocyte receptor cluster. Immunogenetics 51:703-713.
47. Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Rock MJ, Bell RS, and Andrulis IL (2000). MDR1 gene expression and outcome in osteosarcoma: A prospective, multicenter study. J Clin Oncol 18:2685-2694.
48. Yue H, Eastman PS, Wang BB, Minor J, Doctolero MH, Nuttall RL, Stack R, Becker JW, Montgomery JR, Vainer M, and Johnston R (2001). An evaluation of the performance of cDNA microarrays for detecting changes in global mRNA expression. Nucleic Acids Res 29:E41-1.